These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21062727)
21. A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells. Yang CT; You L; Lin YC; Lin CL; Mccormick F; Jablons DM Anticancer Res; 2003; 23(1A):33-8. PubMed ID: 12680192 [TBL] [Abstract][Full Text] [Related]
26. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma. Pass HI Chest Surg Clin N Am; 1994 Aug; 4(3):497-515. PubMed ID: 7953481 [TBL] [Abstract][Full Text] [Related]
27. [Individualized cancer therapy and treatment based on syndrome differentiation]. Wang ZY Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):158-60. PubMed ID: 23714675 [No Abstract] [Full Text] [Related]
28. Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma. Tsao AS; Mehran R; Roth JA Clin Lung Cancer; 2009 Jan; 10(1):36-41. PubMed ID: 19289370 [TBL] [Abstract][Full Text] [Related]
32. Targeted therapy--possible new therapeutic option for malignant mesothelioma? Dobra K; Hjerpe A Connect Tissue Res; 2008; 49(3):270-2. PubMed ID: 18661358 [TBL] [Abstract][Full Text] [Related]
33. [Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis]. Scripcariu V; Dajbog E; Radu I; Ferariu D; Pricop A; Grigoraş M; Dragomir C Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):673-7. PubMed ID: 18293699 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of malignant pleural mesothelioma]. Yusa T Gan To Kagaku Ryoho; 2007 Apr; 34(4):520-6. PubMed ID: 17431335 [TBL] [Abstract][Full Text] [Related]
35. Targeted and personalized therapy for cancer: theory and practice in China. Liu Q; Zhang X; Zeng Y Sci China Life Sci; 2011 Dec; 54(12):1081-4. PubMed ID: 22227898 [No Abstract] [Full Text] [Related]
36. [Malignant pleural mesothelioma: causes, diagnosis and treatment]. Bahm J; Knauf M; Bohndorf K Dtsch Med Wochenschr; 1990 Mar; 115(13):508-13. PubMed ID: 2180673 [No Abstract] [Full Text] [Related]
37. Hyperthermia and mafosfamide in a human-derived malignant pleural mesothelioma cell line. Ehlers EM; Kühnel W; Wiedemann GJ J Cancer Res Clin Oncol; 2002 Feb; 128(2):65-72. PubMed ID: 11862475 [TBL] [Abstract][Full Text] [Related]
38. [Oesophageal cancer: current status of multimodality therapy]. Vallböhmer D; Schröder W; Brabender J; Hölscher AH Zentralbl Chir; 2011 Aug; 136(4):312-6. PubMed ID: 21863509 [TBL] [Abstract][Full Text] [Related]
39. Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression. Spugnini EP; Bosari S; Citro G; Lorenzon I; Cognetti F; Baldi A Int J Biochem Cell Biol; 2006; 38(12):2000-4. PubMed ID: 16963313 [TBL] [Abstract][Full Text] [Related]